Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants With Moderate or Severe Asthma

NCT07120503 is registered in ClinicalTrials.gov with Windward Bio as lead sponsor.

NCT NCT07120503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants With Moderate or Severe Asthma
Lead sponsor
Windward Bio
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 24, 2025
Completion date
October 31, 2027
Enrollment
136 (estimated)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

asthma (diagnosis)